VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Rallybio Corporation (RLYB) Total Return Calculator with Dividends Reinvested

Rallybio Corporation

Popular:

The total return for Rallybio Corporation (RLYB) stock is +510.83% over the past 12 months. So far it's up 159.01% this year. The 5-year total return is -87.00%, meaning $10,000 invested in RLYB stock 5 years ago would be worth $1,300 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in RLYB 1 year ago, it would be worth $61,083 today — you'd have gained $51,083.

With Dividends Reinvested$61,083+510.83%

Price Only (No DRIP)$61,083+510.83%

Period2025-05-07 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in RLYB

1Y$61,083+$51,083 (+510.8%)510.8% CAGR

3Y$3,054-$6,946 (-69.5%)-32.7% CAGR

5Y$1,300-$8,700 (-87.0%)-33.5% CAGR

10Y$1,300-$8,700 (-87.0%)-18.5% CAGR

15Y$1,300-$8,700 (-87.0%)-12.7% CAGR

20Y$1,300-$8,700 (-87.0%)-9.7% CAGR

30Y$1,300-$8,700 (-87.0%)-6.6% CAGR

Rallybio Corporation did not pay dividends during this period. Total return = price return.

Loading RLYB total return...

As of 2026-05-07

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	+159.01%	—	+159.01%	—	$25,901
1Y	+510.83%	510.83%	+510.83%	—	$61,083
3Y	-69.46%	-32.66%	-69.46%	—	$3,054
5Y	-87.00%	-33.51%	-87.00%	—	$1,300
10Y	-87.00%	-18.46%	-87.00%	—	$1,300
15Y	-87.00%	-12.72%	-87.00%	—	$1,300
20Y	-87.00%	-9.70%	-87.00%	—	$1,300
30Y	-87.00%	-6.58%	-87.00%	—	$1,300

Risk & Highlights

Best Year-27.76%2025

Worst Year-61.39%2023

Max Drawdown-89.31%2025-12-19 → 2026-01-24 · Recovered 2026-02-26

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+33.22%	+33.22%	—	+0.41%	+32.8pp
2025	-27.76%	-27.76%	—	+16.64%	-44.4pp
2024	-60.00%	-60.00%	—	+24.00%	-84.0pp
2023	-61.39%	-61.39%	—	+24.81%	-86.2pp
2022	-36.71%	-36.71%	—	-19.95%	-16.8pp

RLYB outperformed the S&P 500 by 480.46pp over the past year (+510.83% vs +30.37%).

Loading summary...

RLYB Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
RLYBRallybio Corporation	$83M	+82.1%	+159.0%	+510.8%	—	-69.5%	-87.0%	-87.0%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
PRAXPraxis Precision Medicines, Inc.	$7.5B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
KYMRKymera Therapeutics, Inc.	$6.9B	-0.6%	+16.3%	+190.7%	—	+205.1%	+92.1%	+154.4%
ARQTArcutis Biotherapeutics, Inc.	$2.6B	-11.2%	-28.8%	+50.8%	—	+44.9%	-39.5%	-5.2%
TPSTTempest Therapeutics, Inc.	$55M	+26.3%	-33.2%	-69.3%	—	-92.6%	-88.0%	-99.9%
RVMDRevolution Medicines, Inc.	$30.3B	+48.0%	+80.3%	+278.4%	—	+483.1%	+382.1%	+393.1%
ALNYAlnylam Pharmaceuticals, Inc.	$39.5B	-7.4%	-26.1%	+7.0%	—	+40.9%	+125.4%	+411.9%
RAREUltragenyx Pharmaceutical Inc.	$2.6B	+12.9%	+10.7%	-21.8%	—	-44.5%	-77.2%	-59.4%
FOLDAmicus Therapeutics, Inc.	$4.5B	+0.1%	+1.5%	+137.9%	—	+19.0%	+48.6%	+119.2%
KRYSKrystal Biotech, Inc.	$8.7B	+12.4%	+20.2%	+116.9%	—	+238.5%	+319.2%	+2688.5%

Compare:RLYB vs IMVT RLYB vs PRAX RLYB vs KYMR RLYB vs IMVT vs PRAX

About RLYB Dividend Returns

Rallybio Corporation (RLYB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of RLYB over the past year?

Rallybio Corporation (RLYB) delivered a return of 510.83% over the past year. Since RLYB does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in RLYB be worth today?

A $10,000 investment in Rallybio Corporation one year ago would be worth $61,083 today, representing a gain of $51,083.

Q3Does RLYB pay dividends?

Rallybio Corporation (RLYB) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For RLYB, the total return equals the price-only return.

Q4Did RLYB beat the S&P 500?

Yes, Rallybio Corporation (RLYB) outperformed the S&P 500 by 480.46 percentage points over the past year. RLYB delivered a total return of 510.83%, compared to the S&P 500's 30.37%. This 480.46pp alpha means investors in RLYB earned more than a passive S&P 500 index fund.

Q5What is RLYB's worst drawdown?

Rallybio Corporation (RLYB) experienced a maximum drawdown of -89.31% over the past year, declining from its peak on 2025-12-19 to its trough on 2026-01-24. The stock recovered to its prior peak by 2026-02-26. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is RLYB's long-term total return over 10, 20, or 30 years?

Here are Rallybio Corporation (RLYB)'s long-term returns with dividends reinvested. Over 10 years, the total return is -87.0% (-18.5% CAGR) — $10,000 would have grown to $1,300. Over 20 years: -87.0% total return (-9.7% CAGR) — $10,000 → $1,300. Over 30 years: -87.0% total return (-6.6% CAGR) — $10,000 → $1,300. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was RLYB's best and worst year?

Rallybio Corporation's best calendar year was 2025 with a total return of -27.8%. Its worst year was 2023 with a total return of -61.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 33.6 percentage points.